Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

489

Full text

397

Free full text

228

Publication Types

Journal Article

499

Research Support, Non-U.S. Gov't

199

Randomized Controlled Trial

180

Multicenter Study

155

Clinical Trial, Phase II

106

Review

103

Clinical Trial, Phase III

Comparative Study

Clinical Trial

Clinical Trial, Phase I

Observational Study

Research Support, N.I.H., Extramural

Case Reports

Meta-Analysis

Systematic Review

Comment

Clinical Trial Protocol

Letter

Equivalence Trial

Research Support, U.S. Gov't, Non-P.H.S.

Consensus Development Conference

Network Meta-Analysis

Controlled Clinical Trial

Editorial

Validation Study

Congress

Practice Guideline

Clinical Trial, Phase IV

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Capecitabine""[mesh_terms]

509 Results

Searching titles within these results

Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge.

Laura B Vater, Bénédicte Lefebvre, Anita Turk, Suparna C Clasen

Current oncology reports 2022;24(7):943-950

Full Text

Abstract

Capecitabine-Induced Ileitis during Neoadjuvant Pelvic Radio-Chemotherapy for Locally Advanced Rectal Cancer: A Case Report with Literature Review.

Andrea Brignoli, Eleonora Ferrara, Micol Zannetti, Gianfranco Loi, Laura Forti, Carlo Socci, Alessandro Carriero, Alessandra Gennari, Marco Krengli, Pierfrancesco Franco

Current oncology (Toronto, Ont.) 2023;30(10):9063-9077

Free Full Text

Abstract

5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review).

Shiekhah M Alzahrani, Huda A Al Doghaither, Ayat B Al-Ghafari, Peter N Pushparaj

Oncology reports 2023;50(4):175

Full Text

Abstract

Proton pump inhibitors and colorectal cancer: A systematic review.

Agastya Patel, Piotr Spychalski, Magdalena Antoszewska, Jaroslaw Regula, Jarek Kobiela

World journal of gastroenterology 2021;27(44):7716-7733

Free Full Text

Abstract

Rare capecitabine-induced acute hypertriglyceridemia with angina: a case report and review of the literature.

Wenyue Zhou, Lu Ni, Manxi Luo, Xinyao Shu, Peng Cao, Meng Qiu

Annals of palliative medicine 2022;11(6):2152-2156

Free Full Text

Abstract

Oral probiotic supplementation to alleviate diarrhea induced by fluoropyrimidines or irinotecan-based chemotherapy: A systematic review and meta-analysis.

Nutthada Areepium, Daylia Thet, Nattawut Leelakanok, Tippawan Siritientong

Complementary therapies in medicine 2025;89():103151

Free Full Text

Abstract

Capecitabine in the treatment of colorectal cancer.

J Cassidy, V J O'Neill

Future oncology (London, England) 2006;1(2):183-90

Full Text

Abstract

Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study).

Akhil Santhosh, Akash Kumar, Raja Pramanik, Ajay Gogia, Chandra Prakash Prasad, Ishaan Gupta, Nishkarsh Gupta, Winson Y Cheung, Ravindra Mohan Pandey, Atul Sharma, Atul Batra

Trials 2022;23(1):420

Free Full Text

Abstract

Activity of Sorafenib Plus Capecitabine in Previously Treated Metastatic Colorectal Cancer.

Thomas J George, Alison M Ivey, Azka Ali, Ji-Hyun Lee, Yu Wang, Karen C Daily, Brian H Ramnaraign, Sanda A Tan, Krista P Terracina, Thomas E Read, Long H Dang, Atif Iqbal

The oncologist 2021;26(5):362-e724

Free Full Text

Abstract

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

Richard Herrmann, György Bodoky, Thomas Ruhstaller, Bengt Glimelius, Emilio Bajetta, Johannes Schüller, Piercarlo Saletti, Jean Bauer, Arie Figer, Bernhard Pestalozzi, Claus-Henning Köhne, Walter Mingrone, Salomon M Stemmer, Karin Tàmas, Gabriela V Kornek, Dieter Koeberle, Susanne Cina, Jürg Bernhard, Daniel Dietrich, Werner Scheithauer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2212-7

Full Text

Abstract

Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.

John Bridgewater, Peter Fletcher, Daniel H Palmer, Hassan Z Malik, Raj Prasad, Darius Mirza, Alan Anthony, Pippa Corrie, Stephen Falk, Meg Finch-Jones, Harpreet Wasan, Paul Ross, Lucy Wall, Jonathan Wadsley, Thomas R Evans, Deborah Stocken, Clive Stubbs, Raaj Praseedom, Yuk Ting Ma, Brian Davidson, John Neoptolemos, Tim Iveson, David Cunningham, O James Garden, Juan W Valle, John Primrose

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022;40(18):2048-2057

Full Text

Abstract

A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients.

Chiara Baratelli, Clizia Zichi, Massimo Di Maio, Maria Pia Brizzi, Cristina Sonetto, Giorgio Vittorio Scagliotti, Marco Tampellini

Critical reviews in oncology/hematology 2018;122():21-29

Full Text

Abstract

Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE).

Baek-Yeol Ryoo, Min-Hee Ryu, Yoon-Koo Kang, Kyung Hee Lee, Lin Shen, Kun-Huei Yeh, Changhoon Yoo, Young Seon Hong, Young Iee Park, Sung Hyun Yang, Dong Bok Shin, Dae Young Zang, Won Ki Kang, Ik-Joo Chung, Yeul Hong Kim, Byung-Ho Nam, Young Soo Park

Cancer medicine 2023;12(7):7784-7794

Free Full Text

Abstract

Carbohydrate polymers-based surface modified nano delivery systems for enhanced target delivery to colon cancer - A review.

Ibrahim Abdel Aziz Ibrahim, Abdullah R Alzahrani, Ibrahim M Alanazi, Naiyer Shahzad, Imran Shahid, Alaa Hisham Falemban, Mohd Fahami Nur Azlina, Palanisamy Arulselvan

International journal of biological macromolecules 2023;253(Pt 2):126581

Full Text

Abstract

"New" metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy.

Christopher Twelves, Javier Cortes, Peter A Kaufman, Louise Yelle, Ahmad Awada, Terri A Binder, Martin Olivo, James Song, Joyce A O'Shaughnessy, Maria Jove, Edith A Perez

Breast cancer research : BCR 2018;17(1):150

Free Full Text

Abstract

Results: 1 – 15 / 509

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Capecitabine""[mesh_terms]

Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge.

Capecitabine-Induced Ileitis during Neoadjuvant Pelvic Radio-Chemotherapy for Locally Advanced Rectal Cancer: A Case Report with Literature Review.

5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review).

Proton pump inhibitors and colorectal cancer: A systematic review.

Rare capecitabine-induced acute hypertriglyceridemia with angina: a case report and review of the literature.

Oral probiotic supplementation to alleviate diarrhea induced by fluoropyrimidines or irinotecan-based chemotherapy: A systematic review and meta-analysis.

Capecitabine in the treatment of colorectal cancer.

Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study).

Activity of Sorafenib Plus Capecitabine in Previously Treated Metastatic Colorectal Cancer.

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.

A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients.

Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE).

Carbohydrate polymers-based surface modified nano delivery systems for enhanced target delivery to colon cancer - A review.

"New" metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy.

Results for
""Capecitabine""[mesh_terms]